Smartphone-based home screening significantly boosts chronic kidney disease (CKD) diagnosis and follow-up care, enhancing ...

With CT scans picking up more cases of sclerosing mesenteritis, be prepared to diagnose this poorly understood autoimmune ...

Altimmune’s pemvidutide failed to significantly improve fibrosis in MASH patients in a Phase IIb study. The biotech crashed ...

Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients ...

Tempus AI TEM, a Chicago-based company focused on precision medicine, is building network effects via its three interconnected product lines. In the first quarter of 2025, revenues in its Data and ...

Adults with type 2 diabetes and chronic kidney disease have a lower risk for adverse renal outcomes with semaglutide, ...

Between 14 days and 1 day out from an acute exacerbation of COPD, a digital inhaler measured significant drops in inhalation ...

SNS Insider Highlights Surging U.S. Companion Animal Health Market—Valued at USD 6.85 Billion in 2023—Driven by Expanding Veterinary Infrastructure and Heightened Pet Care Spending Across North ...

The Obesity Drug Development Summit Europe is your perfect platform to be in a prime position to be at the forefront of this ...

As practicing oncologists, we can get bogged down in our individual practices and thus have trouble seeing the bigger picture ...

The global pet hypothyroidism therapy market is expected to reach USD 216.2 million in 2025 and is projected to grow to USD ...